- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05568810
The Study of Adenoma Characteristics of the COX-2 and DNMT Expressions in the Index Colonoscopy to Predict the Polyp Recurrence During Surveillance
October 3, 2022 updated by: National Cheng-Kung University Hospital
The colorectal cancer is the first incidence and ranks the third cancer-death cause in Taiwan.
Based on the Taiwan-national colon cancer screening program, early colorectal cancer detection rate and the survival are markedly improved.
Besides to disclose the early cancer, there are vast populations to be disclosed with colon adenoma.
Some of colon adenoma really presents as advanced colon adenoma (ACA) to carry higher risk of recurrence and even cancer progression.
The current clinical guidelines raise strategy for colonoscopy surveillance based on the results of the index colonoscopy to categorize the patients into different risks of colon polyp recurrence and early detection of colorectal cancer.
It is worthy to validate whether the real scenario of Taiwan colonoscopy surveillance can fulfill the guidelines worldwide.
Furthermore, it shall be of clinical importance to elucidate out the high risky group who may be commonly disclosed during intense colonoscopy surveillance and to disclose with advanced adenoma.
Accordingly, the domestic amending to the worldwide guideline shall be in need and need a more reliable biomarker to predict the recurrence of colon adenoma during surveillance colonoscopy.
Concerning, cyclooxygenase-2 (COX-2) and DNA methyltransferases (DNMT) are involved during colorectal carcinogenesis via chronic inflammatory process and early tumorigenesis.
This study proposes COX-2 and DNMT shall be potential biomarkers correlating to the recurrence of colon adenoma disclosed during surveillance colonoscopy in Taiwan.
We thus conduct a prospective study, containing at least 1,400 cases, who will undergo surveillance colonoscopy in National Cheng Kung University Hospital in the next year.
The study shall be a large-case study to answer whether the surveillance interval of the surveillance colonoscopy can be fulfilled to the suggestion of the 2012 United States Multi-society Task Force (USMTF) on colorectal cancer guideline.
Factors that affect the detection of polyps in the surveillance will be explored.
Based on the invitation of the patients to receive surveillance colonoscopy, the study also test whether COX-2 or DNMT over-expression are markers to predict polyps recurrence and to identify the risky patient deserve for earlier colonoscopy.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
831
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who receive surveillance colonoscopy during the study period at National Cheng Kung University Hospital, a tertiary referral medical center in Taiwan, are enrolled in the study
Description
Inclusion Criteria:
- Patients who receive surveillance colonoscopy during the study period at National Cheng Kung University Hospital, a tertiary referral medical center in Taiwan, are enrolled in the study
Exclusion Criteria:
- poor bowel preparation, failed cecal intubation, contraindication for biopsy or polypectomy, patients with a history of inflammatory bowel disease, and those who are under 18 years old, decline to join the study, or do not have previous colonoscopy conducted in our institute
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the compatibility of surveillance colonoscopy with the USMTF guideline in Taiwan
Time Frame: usual the exam of colonoscopy: 10 min to 60 min
|
To determine the compatibility of surveillance colonoscopy with the USMTF guideline for different histological features of colon adenoma at index colonoscopy in Taiwan
|
usual the exam of colonoscopy: 10 min to 60 min
|
|
Factors that affect the detection of polyps in the surveillance
Time Frame: usual the exam of colonoscopy: 10 min to 60 min
|
To explore factors that affect the detection of polyps in the surveillance
|
usual the exam of colonoscopy: 10 min to 60 min
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Wei-Ying Chen, MD, National Cheng-Kung University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 1, 2014
Primary Completion (ACTUAL)
July 31, 2016
Study Completion (ACTUAL)
July 31, 2016
Study Registration Dates
First Submitted
October 3, 2022
First Submitted That Met QC Criteria
October 3, 2022
First Posted (ACTUAL)
October 6, 2022
Study Record Updates
Last Update Posted (ACTUAL)
October 6, 2022
Last Update Submitted That Met QC Criteria
October 3, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- A-ER-102-436
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colon Polyp
-
Robert Bosch Gesellschaft für Medizinische Forschung...Ovesco Endoscopy AG; Tuebingen Scientific Medical GmbHRecruitingAdenoma Colon | Adenoma Colon PolypGermany
-
University of ManitobaCompletedPolyps | Colonic Polyp | Polyp of Colon | Colo-rectal Cancer | Colon Polyp | Rectal Polyp | Polyp RectalCanada
-
Medical University of ViennaCompletedMultiple Polyps Right Colon | Large Polyp Right Colon | Suspected Polyp Right ColonAustria
-
University College, LondonRecruitingPolyps | Colon Polyp | Adenoma Colon | Colorectal Polyp | Polyps of ColonUnited Kingdom
-
Rambam Health Care CampusNot yet recruitingPolyp Colorectal | Colon Cancer PreventionIsrael
-
University College, LondonCompletedPolyps | Colon Polyp | Adenoma Colon | Colorectal PolypUnited Kingdom
-
United States Naval Medical Center, PortsmouthWithdrawnColon Polyps | Colon Cancer ScreeningUnited States
-
Istituto Clinico HumanitasCompletedColon Adenoma | Colon Polyp | Colon LesionItaly
-
Queen's UniversityHotel Dieu Hospital (Gastrointestinal Diseases Research Unit)CompletedQuality of Bowel Preparation for the Colon Capsule | Colon Capsule Completion Rates | Colon Capsule Polyp DetectionCanada
-
IRCCS San RaffaeleUnknown